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Abstract 
Background 
While low oxygen saturations are generally regarded as deleterious, recent studies in intensive care unit (ICU) patients 
have shown that a liberal oxygen strategy increases mortality. However, the optimal oxygen saturation target remains 
unclear. We therefore aimed to elucidate this optimal range with real world data. 
Methods 
Replicate retrospective analyses of two electronic medical record databases were done: eICU Collaborative Research 
Database (eICU-CRD) and the Medical Information Mart for Intensive Care III (MIMIC). Only patients with at least 
48 hours of oxygen therapy were included. Nonlinear regression was used to analyze the association between median 
pulse oximetry-derived oxygen saturation (SpO2) and hospital mortality. We derived an optimal range of SpO2 and 
analyzed the association between the percentage of time within the optimal range of SpO2 and hospital mortality. All 
models adjusted for age, body mass index, gender, and SOFA score. Subgroup analyses included ICU types, main 
diagnosis, and comorbidities. 
Results 
We identified 26,723 patients from eICU-CRD and 8,564 patients from MIMIC. The optimal range of SpO2 was 94–
98% in both eICU-CRD and MIMIC. The percentage of time patients were within the optimal range of SpO2 was 
associated with decreased hospital mortality (odds ratio of 80% versus 40% of the measurements within the optimal 
range: 0.42, 95% CI 0.40 to 0.43, for eICU-CRD and 0.53, 95% CI 0.50 to 0.55 for MIMIC). This association was 
consistent across subgroup analyses. 
Conclusions 
The optimal range of SpO2 was 94–98% and should inform future trials of oxygen therapy. 
Keywords 
Blood oxygen saturation; electronic medical records; hyperoxemia; intensive care unit; oxygen therapy; pulse oximetry  
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Introduction 
Human survival requires adequate tissue oxygenation, which depends on blood oxygenation. In critically ill patients with 
cardiorespiratory compromise, blood oxygen levels – commonly measured continuously using peripheral pulse oximetry 
(SpO2) or intermittently using arterial blood gas analysis (PaO2) – are supported by methods such as supplemental 
oxygen, mechanical ventilation and extracorporeal membrane oxygenation. However, an optimal target range of blood 
oxygenation in critically ill patients requiring oxygen therapy has not been defined. 
The relationship between blood oxygenation and clinical outcomes is unlikely to be linear. Low blood oxygenation 
predisposes to tissue hypoxia and eventual cellular death. High blood oxygenation may induce vasoconstriction of 
important vascular beds, e.g. cerebral or coronary, and generates free radicals that cause cellular damage.1 Since high 
inspired oxygen concentrations can drive high blood oxygenation, direct lung toxicity and atelectasis can also occur.1,2 
As such, blood oxygenation and outcomes likely have a U-shaped relation, though few empirical studies support this 
directly. 
The available evidence, listed in the supplement, has four broad issues. Firstly, investigators are predisposed to 
demonstrate the harmful effects of hyperoxemia but not hypoxemia. For instance, a recent systematic review of 25 
randomized trials demonstrated that supplemental oxygen targeting SpO2 >96% increased mortality compared to SpO2 
<96%, but did not define a lower limit of safety.3 Secondly, some studies assumed a linear relationship between 
oxygenation and mortality,4 which is biologically implausible. Thirdly, some studies used PaO2 rather than SpO2 to 
define oxygenation.4-6 As PaO2 cannot be continuously assayed, this method would have limited resolution in detecting 
hyperoxemia or hypoxemia, and would not allow correlation of outcomes with the proportion of time spent within a 
target oxygenation range. Interestingly, one study involving septic patients showed optimal survival at a PaO2 of 300 
mmHg,7 which is considered hyperoxemia by other studies. Finally, randomized trials8,9 and some observational 
studies6,10-13 defined oxygen in arbitrarily defined categories rather than as a continuous variable, and were therefore 
unable to define an optimal target range. Furthermore, using categories that include both healthy and unhealthy 
oxygenation ranges simultaneously could lead to inconsistent results.3,5 For instance, a cohort study showed higher 
mortality for normoxemia, defined as a PaO2 between 60-120 mmHg, than for hypoxemia, defined as <60 mmHg.10 
Additionally, there are reports14-17 that hyperoxemia is common in the ICU, with hyperoxemia rates published ranging 
from 15% to over 70% of ICU patients, and physicians intervening only limitedly. There are often no clear oxygen 
therapy guidelines that are being followed. The lack of evidence on the optimal oxygenation target contributes to this. 
With hyperoxemia’s adverse effects, its prevalence provides an opportunity to improve outcomes. 
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A large-scale multicentre study is therefore required to elucidate oxygen saturation targets to guide clinical practice and 
future research. This is now possible using big data sources such as the eICU Collaborative Research Database18 (eICU-
CRD) and the Medical Information Mart for Intensive Care III19 (MIMIC) which are open-access, de-identified data sets 
of patients admitted to ICUs. Without making assumptions of linearity, our study aims to derive an optimal range of 
oxygen saturation by correlating SpO2 with mortality. We then evaluate this oxygen saturation range by correlating the 
time within this range with mortality. Replicate analyses using eICU-CRD and MIMIC demonstrate the reliability of our 
findings. 
Materials and Methods 
Data Description 
We collected data from eICU-CRD v2.0 and MIMIC-III v1.4 in accordance with the ethical standards of the institutional 
review board of the Massachusetts Institute of Technology (no. 0403000206) and with the 1964 Helsinki declaration and 
its later amendments. eICU-CRD covers 200,859 ICU admissions in 2014 and 2015 of 139,367 patients at 208 U.S. 
hospitals. MIMIC covers 61,532 ICU admissions between 2001 and 2012 of 46,476 patients at the Beth Israel Deaconess 
Medical Center in Boston, MA, USA. Both databases are maintained by the Laboratory for Computational Physiology at 
the Massachusetts Institute of Technology. They include hourly physiologic readings from bedside monitors, records of 
demographics, diagnoses via International Classification of Diseases, Ninth Revision (ICD-9) codes and other clinical 
data, collected during routine medical care. The databases have extensive documentation and public code from a 
community of users.20 This study is reported in accordance with the STrengthening the Reporting of OBservational 
studies in Epidemiology (STROBE) statement.21 
The primary outcome was hospital mortality with ICU mortality as a secondary outcome. The primary independent 
variable was SpO2 while on oxygen therapy, where oxygen therapy can be supplemental oxygen such as a nasal cannula, 
non-invasive, and invasive ventilation. We took the median of the SpO2 measurements during oxygen therapy as a 
measure of the central tendency of oxygen exposure. Additionally, we considered the proportion of measurements within 
a range to evaluate oxygen therapy. SpO2 is usually measured hourly in eICU-CRD and MIMIC. The measurements were 
verified and entered into a chart by a nurse. 
We excluded repeat ICU stays, patients under 16, and ICU stays with less than 48 hours of oxygen therapy, with fewer 
than 24 SpO2 measurements or with no signs of supplemental oxygen such as a fraction of inspired oxygen (FiO2) above 
21% or records of an oxygen flow rate. Like SpO2, a nurse enters FiO2 and oxygen flow rate regularly such that our 
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determination of who is on supplemental oxygen is reliable. We included only hospitals that contained at least ten ICU 
stays in the data cohort to improve identifiability of the resulting statistical model. 
Statistical Analysis 
That both hypoxemia and hyperoxemia are associated with adverse outcomes suggests a nonlinear relationship between 
SpO2 and mortality. Generalized additive models,22 a type of multivariable regression, allow for such nonlinearity. We 
used them to estimate the association between median SpO2 and mortality while controlling for age, body mass index 
(BMI), gender, Sequential Organ Failure Assessment (SOFA) score23 on the first day of the ICU stay, and duration of 
oxygen therapy (i.e. any oxygen supplementation, non-invasive ventilation or mechanical ventilation). Additionally, for 
eICU-CRD, we included hospital as a random intercept to capture the correlation between cases from the same hospital 
while mitigating biases due to differences between hospitals. The results informed an optimal oxygen therapy range. We 
then estimated the association between mortality and the proportion of SpO2 measurements within this range. All 
continuous predictors were treated as having potentially nonlinear associations. 
The supplement contains additional cohort characteristics, sensitivity and subgroup analyses, results with ICU mortality 
(secondary outcome), results on the ICU stays excluded here because they did not have 48 hours of oxygen therapy or 
too few SpO2 measurements, and confirmatory results using G-computation (a method to estimate the causal effect of 
SpO2 on hospital mortality). To address concerns about time dependency of oxygen exposure, sensitivity analyses 
consider only using the SpO2 measurements during the first 24, 48, or 72 hours of an oxygen therapy session. Since 
APACHE IV score24 is readily available in eICU-CRD, one sensitivity analysis is to use that score instead of SOFA score 
as control variable. Subgroup analyses include oxygen therapy type, ICU type, ethnicity, and the presence of 
comorbidities such as atrial fibrillation and chronic obstructive pulmonary disease. 
Source code for all analyses can be found at https://github.com/nus-mornin-lab/oxygenation_kc upon publication of this 
article. 
Results 
Figure 1 describes the selection of 26,723/8,564 ICU stays meeting our criteria from the 200,859/61,532 ICU stays in 
eICU-CRD/MIMIC for analysis. Table 1 summarizes the demographic and clinical characteristics. Hospital mortality and 
SOFA scores are higher in those selected than in eICU-CRD and MIMIC overall. This is probably a result of only 
selecting ICU stays that involved oxygen therapy for at least 48 hours. The characteristics of the SpO2 measurements are 
similar across eICU-CRD and MIMIC. 
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Figure 2 shows a U-shaped association between mortality and median SpO2 (P<0.0001 for both eICU-CRD and 
MIMIC). While hypoxemia correlates more strongly with mortality, hyperoxemia is also associated with increased 
mortality. Table 2 confirms this, both when adjusting for confounders and when not adjusting for them. We chose the 
median SpO2 values 100%, 96%, and 92% in Table 2 based on that the bottom of the U-shape in Figure 2 occurs around 
96%, and added 92% and 100% for symmetry. 
The effect of hypoxemia and hyperoxemia on mortality motivates an SpO2 range with both a lower and an upper limit. 
Informed by the flattest part of the U-shape in Figure 2, we chose an SpO2 range of 94–98%. Next, we evaluate how time 
in this range correlates with mortality. 
Figure 3 shows the association of mortality with time in this range, as well as with the proportion of SpO2 measurements 
below and above this range (P<0.0001 for all associations in both eICU-CRD and MIMIC). Being within this range 80% 
of the time versus 40% of the time is associated with reducing the odds of mortality by half in both eICU-CRD (adjusted 
odds ratio 0.42, 95% CI 0.40 to 0.43) and MIMIC (adjusted odds ratio 0.53, 95% CI 0.50 to 0.55) per Table 2: We chose 
to present the comparison 80% versus 40% of SpO2 measurements between 94–98% in Table 2 because 40% appears 
frequently in the data per Table 1 and achieving 80% seems feasible: 7%/5% of the analysed eICU-CRD/MIMIC data 
have more than 80% of SpO2 measurements between 94–98%. e-Figure 30 further shows the distribution of these 
proportions in the data. Table 2 and Figures 3C and 3D confirm that SpO2 above 98% is indeed associated (P<0.0001 for 
both eICU-CRD and MIMIC) with increased hospital mortality, supporting the need for an upper limit to a target range. 
The sensitivity and subgroup analyses in the supplement are consistent with these results except that the uncertainty is 
larger for some subgroups with small sample sizes. 
Discussion 
Our replicate analyses of two large databases consistently demonstrated that, among patients requiring oxygen therapy, 
hospital mortality had a U-shaped association with SpO2. The retrospective data exhibited lowest mortality at a median 
SpO2 within 94–98%, and when patients spent a greater proportion of time within this range. These results were similar 
for different modes of oxygen therapy, across diagnostic and comorbidity subgroups, and when ICU mortality was used 
in place of hospital mortality. 
Our sensitivity analyses involving using early SpO2 readings, within 24, 48 and 72 hours of ICU admission, showed the 
same as our primary analysis using all SpO2 readings. These suggest that disease recovery, as shown by improved 
mortality, was not responsible for SpO2 within the evaluated 94–98% range, and that SpO2 within that range was equally 
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associated with reduced mortality throughout the ICU stay. Also, subgroup, sensitivity, and replicate analyses using both 
the eICU-CRD and MIMIC showed consistent results, while medical practice is continually evolving: MIMIC represents 
older practice patterns from 2001-2012. eICU-CRD represents more contemporary practice patterns from 2014-2015. 
An alternative means of measuring blood oxygenation is PaO2. However, SpO2 provides pragmatic advantages over 
PaO2, including the ability to measure oxygenation cheaply, noninvasively and repeatedly. SpO2 is also clinically more 
relevant as adjustments of inspired oxygen and ventilator settings are based on SpO2 changes rather than on intermittent 
arterial blood gas assays. For the SpO2 range of 94–98%, the correlation between SpO2 and PaO2 would be fair, with 
little risk of underestimation of either hypoxemia or hyperoxemia.25 Furthermore, using SpO2 to titrate supplemental 
oxygen is superior to fixed inspired oxygen fractions, which risk over-oxygenation in patients with narrow alveolar-
arterial oxygen gradients, and under-oxygenation in those with wide gradients. 
Interestingly, one randomized trial showed that a target SpO2 of 94–98% conferred a mortality benefit compared to using 
a target of 97-100% (ICU mortality 11.6% versus 22.0%, P=0.01; hospital mortality 24.2% versus 33.9%, P=0.03).8 
Although the trial was non-blinded, it supports our range of 94–98%. In contrast to relative normal blood oxygenation, 
trials in paediatric populations demonstrate mortality from permissive hypoxemia (SpO2 85–89%).27,28 Our study also 
found that SpO2 <94% was associated with increased mortality, reinforcing the need for caution if adult trials incorporate 
permissive hypoxemia. 
Our results are potentially impactful and support the British Thoracic Society recommended target of 94–98% for most 
acutely ill patients.29 Recent evidence suggests that overuse of oxygen therapy is prevalent and is associated with adverse 
outcomes including more days on mechanical ventilation and longer hospitalization.14-17 Targeting SpO2 between 94 to 
98% might optimize survival for patients requiring oxygen therapy.30 As pulse oximetry is widespread and affordable, 
implementation of the 94–98% target would be feasible, even in resource-limited environments. 
Although our study provides observational evidence for an SpO2 target range of 94–98%, the target would not apply 
under some circumstances. For patients with severe acute respiratory distress syndrome, ventilator settings need to limit 
lung stress and strain.31 A lower limit of SpO2 below 94% could then be the target, as long as patients do not develop 
tissue hypoxia. Our results also do not extend to patients who are not hypoxemic, who are at high risk for hypercapnic 
respiratory failure, who are on extracorporeal membrane oxygenation, or who are not on oxygen therapy since we did not 
include them in our analysis. 
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Despite the large sample size, allowing multiple subgroup and sensitivity analyses, we acknowledge limitations. Firstly, 
the data were from the U.S., so the results may not apply fully to ICUs elsewhere with different practices or resources. 
Secondly, even though we adjusted for covariates, residual confounding could exist. In particular, confounding by 
indication would mean overestimation of the association between hypoxemia and mortality, which we mitigated by 
adjusting for disease severity and by demonstrating consistency of our results using subgroup analysis by disease type. 
Conversely, we would have underestimated the association between hyperoxemia and mortality, though this association 
remained statistically significant in our analyses given the large sample size. 
Importantly, the range of 94–98% was determined retrospectively without knowledge of the oxygen saturation targeted 
by the oxygen therapy. To completely overcome confounding, randomized trials would be the ideal study design. 
Blinding of care providers to the blood oxygenation targets would be possible by electronically altering pulse 
oximeters.27 In prior randomized trials of oxygen therapy, the treatment-group cut-offs for SpO2 or PaO2 were essentially 
arbitrary. Our study provides a firmer basis for selection of SpO2 targets within treatment groups. Given the U-shaped 
relationship between SpO2 and mortality, perhaps three, rather than two, treatment groups are required to compare 
therapeutic effects when blood oxygen exceeds, stays within, or goes below the target range. 
Conclusions 
Among patients requiring oxygen therapy, lowest mortality was observed at an SpO2 between 94–98%. This range 
should apply broadly across different patient characteristics and settings. Future randomized trials could also adopt SpO2 
94–98% as the reference target. 
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Table 1. Demographic and clinical characteristics 
Characteristic 
Mean or count 
(%) 
Standard 
deviation 
Quartiles 
Q1 Median Q3 
 
Data set 
 
112,755 ICU stays from eICU-CRD with demographic data 
Age 62 17 52 64 75 
BMI 29 8.2 24 28 33 
SOFA score 4.5 3.2 2.0 4.0 6.0 
Hospital mortality 10,417 (9%)    
Female 50,987 (45%) 
 
   
 
Data set 
 
26,723 ICU stays from eICU-CRD with at least 48 hours of oxygen therapy and 24 
SpO2 measurements 
Age 64 15 55 66 76 
BMI 30 8.9 24 28 34 
SOFA score 6.0 3.4 4.0 6.0 8.0 
Hospital mortality 3,841 (14%)    
Female 12,120 (45%)     
Oxygen therapy duration 
(hours) 157 155 71 109 185 
Median SpO2 (%) 97 2.0 96 97 99 
Prop. of SpO2 94–98% 0.53 
 
0.21 0.39 0.56 0.68 
 
Data set 
 
18,105 ICU stays from MIMIC with demographic data 
Age 64 16 54 65 76 
BMI 29 7.2 24 27 32 
SOFA score 4.5 3.1 2.0 4.0 6.0 
Hospital mortality 1,783 (10%)     
Female 6,937 (38%)    
     
 
Data set 
 
8,564 ICU stays from MIMIC with at least 48 hours of oxygen therapy and 24 SpO2 
measurements 
Age 64 16 55 67 77 
BMI 29 7.7 24 28 32 
SOFA score 5.5 3.4 3.0 5.0 8.0 
Hospital mortality 1,250 (15%)     
Female 3,449 (40%)    
Oxygen therapy duration 
(hours) 205 228 74 122 240 
Median SpO2 (%) 97 1.7 96 98 99 
Prop. of SpO2 94–98% 0.54 0.19 0.41 0.56 0.68 
      
Summary statistics of demographic and clinical characteristics for the eICU-CRD and MIMIC ICU stays not 
constrained by and constrained by having 48 hours of oxygen therapy and 24 SpO2 measurements. 
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Figure legends 
Fig. 1 Case inclusion flowchart 
Visual representation of how the 26,723/8,564 ICU stays that we analyzed were selected from the 200,859/61,532 ICU 
stays in eICU-CRD/MIMIC. 
 
Fig. 2 Probability of hospital mortality versus median SpO2  
Visual summary of the association between median blood oxygen saturation and probability of hospital mortality from 
the generalized additive model fit on 26,723/8,564 ICU stays from eICU-CRD/MIMIC (A/B). The line is the mean 
prediction and the dashed lines are the 95% confidence interval. 
 
Fig. 3 Probability of hospital mortality versus the proportion of time with SpO2 within 94% to 98% 
Visual summary of the association between the proportion of SpO2 measurements from 94% to 98% and probability of 
hospital mortality from the generalized additive model fit on 26,723/8,564 ICU stays from eICU-CRD/MIMIC (A/B) 
as well as the same for the proportion of measurements below 94% and above 98% (C/D). The lines are the mean 
prediction and the dashed lines are the 95% confidence interval. 
Table 2. Odds ratios (95% confidence interval) of hospital mortality based on the median of SpO2 measurements and 
derived SpO2 range 
Comparison Median SpO2 80% versus 40% of SpO2 measurements 92% versus 96% 100% versus 96% within 94% to 98% above 98% 
 
eICU-CRD  
Adjusted 3.2 (2.9–3.5) 1.6 (1.5–1.6) 0.42 (0.40–0.43) 1.19 (1.16–1.22) 
Unadjusted 
 
2.5 (2.3–2.8) 2.0 (2.0–2.1) 0.33 (0.32–0.38) 1.39 (1.36–1.42) 
 
MIMIC  
   
Adjusted 5.8 (4.8–6.9) 1.2 (1.1–1.3) 0.53 (0.50–0.55) 1.28 (1.19–1.38) 
Unadjusted 
 
4.8 (3.9–6.0) 1.3 (1.2–1.3) 0.51 (0.48–0.55) 1.25 (1.15–1.35) 
Odds ratios of hospital mortality with 95% confidence intervals in parentheses from the generalized additive models on the 
effect of median SpO2, proportion of SpO2 measurements between 94% to 98%, and proportion of SpO2 measurements above 
98%. The odds ratios are computed with (adjusted) and without (unadjusted) controlling for confounders. 
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e-Table 1. Cohort diagnoses and comorbidities 
Diagnosis Count Percentage 
 
Data set 
 
112,755 ICU stays from eICU-CRD with demographic data 
Atrial fibrillation 14,458 13% 
Cancer 5,258 5% 
Congestive heart failure 8,109 7% 
Chronic kidney disease 7,485 7% 
Chronic liver disease 1,074 1% 
Chronic obstructive pulmonary disease 8,489 8% 
Diabetes mellitus 3,606 3% 
Hypertension 15,187 13% 
Ischemic heart disease 9,371 8% 
Sepsis 8,448 7% 
Stroke 2,742 2% 
 
Data set 
 
26,723 ICU stays from eICU-CRD with at least 48 hours of oxygen therapy and 24 
SpO2 measurements 
Atrial fibrillation 4,550 17% 
Cancer 1,413 5% 
Congestive heart failure 2,795 10% 
Chronic kidney disease 2,115 8% 
Chronic liver disease 284 1% 
Chronic obstructive pulmonary disease 2,878 11% 
Diabetes mellitus 493 2% 
Hypertension 3,637 14% 
Ischemic heart disease 2,075 8% 
Sepsis 2,750 10% 
Stroke 597 2% 
 
Data set 
 
18,105 ICU stays from MIMIC with demographic data 
Atrial fibrillation 6,884 38% 
Cancer 2,040 11% 
Congestive heart failure 4,503 25% 
Chronic kidney disease 1,721 10% 
Chronic liver disease 942 5% 
Chronic obstructive pulmonary disease 3,145 17% 
Diabetes mellitus 4,943 27% 
Hypertension 10,351 57% 
Ischemic heart disease 8,109 45% 
Sepsis 1,911 11% 
Stroke 525 3% 
 
Data set 
 
8,564 ICU stays from MIMIC with at least 48 hours of oxygen therapy and 24 SpO2 
measurements 
Atrial fibrillation 3,838 45% 
Cancer 984 11% 
Congestive heart failure 2,633 31% 
Chronic kidney disease 881 10% 
Chronic liver disease 532 6% 
Chronic obstructive pulmonary disease 1,656 19% 
Diabetes mellitus 2,389 28% 
Hypertension 4,806 56% 
Ischemic heart disease 3,701 43% 
Sepsis 1,327 15% 
Stroke 372 4% 
Prevalence of the diagnoses and comorbidities considered in the subgroup analysis for the ICU-CRD and MIMIC ICU stays not constrained by 
and constrained by having 48 hours of oxygen therapy and 24 SpO2 measurements. 
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Secondary outcome 
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e-Figure 1. Probability of ICU mortality versus median SpO2 with ICU mortality as outcome 
These plots are analogous to Figure 2 of the main text but use ICU mortality instead of hospital mortality as outcome. 
e-Figure 2. Probability of ICU mortality versus the proportion of time with SpO2 within 94% to 98% with ICU 
mortality as outcome 
These plots are analogous to Figures 3A and 3B of the main text but use ICU mortality instead of hospital mortality as 
outcome. 
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Sensitivity analyses 
The first sensitivity analysis considers the ICU stays that were excluded because their first oxygen therapy session 
lasted less than 48 hours. Specifically, we consider the 36,021/4,827 ICU stays from eICU-CRD/MIMIC that were not 
repeat stays, had demographic data, underwent oxygen therapy for less than 48 hours, had FiO2 above 21% or a record 
of oxygen flow rate at least once, and had at least one SpO2 measurement. We present the results as in Figures 2, 3A, 
and 3B but with a different range on the vertical axis. 
Mortality is lower in this subset compared to the main text. Also, the median SpO2 is less stable due to the lower 
number of SpO2 measurements. Nonetheless, the U-shaped relation from Figure 2 and downward trend from Figure 3 
of the main text are also present here. 
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e-Figure 3. Probability of hospital mortality versus median SpO2 for cases with less than 48 hours of oxygen therapy 
These plots are analogous to Figure 2 of the main text and consider the set of ICU stays described at the top of this page 
which does not overlap with the sample analyzed in the main text. 
e-Figure 4. Probability of hospital mortality versus the proportion of time with SpO2 within 94% to 98% for cases 
with less than 48 hours of oxygen therapy 
These plots are analogous to Figures 3A and 3B of the main text and consider the set of ICU stays described at the top of 
this page which does not overlap with the sample analyzed in the main text. 
 4 
 
The second sensitivity analysis is that we only consider the first 24, 48, or 72 hours of each oxygen therapy session 
while computing summaries of SpO2 measurements. 
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e-Figure 5. Probability of hospital mortality versus median SpO2 including only SpO2 measurements within the first 
24 hours 
These plots are analogous to Figure 2 of the main text but only use SpO2 measurements during the first 24 hours of the first 
oxygen therapy session of 25,505/8,533 ICU stays from eICU-CRD/MIMIC that had at least 12 SpO2 measurements in this 
period. 
e-Figure 6. Probability of hospital mortality versus the proportion of time with SpO2 within 94% to 98% during the 
first 24 hours 
These plots are analogous to Figures 3A and 3B of the main text but only use SpO2 measurements during the first 24 hours 
of the first oxygen therapy session of 25,505/8,533 ICU stays from eICU-CRD/MIMIC that had at least 12 SpO2 
measurements in this period. 
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e-Figure 7. Probability of hospital mortality versus median SpO2 including only SpO2 measurements within the first 
48 hours 
These plots are analogous to Figure 2 of the main text but only use SpO2 measurements during the first 48 hours of the first 
oxygen therapy session of 25,385/8,547 ICU stays from eICU-CRD/MIMIC that had at least 24 SpO2 measurements in this 
period. 
e-Figure 8. Probability of hospital mortality versus the proportion of time with SpO2 within 94% to 98% during the 
first 48 hours 
These plots are analogous to Figures 3A and 3B of the main text but only use SpO2 measurements during the first 48 hours 
of the first oxygen therapy session of 25,385/8,547 ICU stays from eICU-CRD/MIMIC that had at least 24 SpO2 
measurements in this period. 
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e-Figure 9. Probability of hospital mortality versus median SpO2 including only SpO2 measurements within the first 
72 hours 
These plots are analogous to Figure 2 of the main text but only use SpO2 measurements during the first 72 hours of the first 
oxygen therapy session of 24,885/8,552 ICU stays from eICU-CRD/MIMIC that had at least 36 SpO2 measurements in this 
period. 
e-Figure 10. Probability of hospital mortality versus the proportion of time with SpO2 within 94% to 98% during 
the first 72 hours 
These plots are analogous to Figures 3A and 3B of the main text but only use SpO2 measurements during the first 72 hours 
of the first oxygen therapy session of 24,885/8,552 ICU stays from eICU-CRD/MIMIC that had at least 36 SpO2 
measurements in this period. 
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The third sensitivity analysis considers controlling for APACHE IV score instead of SOFA score. 
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e-Figure 11. Probability of hospital mortality versus median SpO2 while controlling for APACHE score 
These plots are analogous to Figure 2 of the main text but control for APACHE instead of SOFA score while fitting the 
model on 24,885/8,564 ICU stays from eICU-CRD/MIMIC that have an APACHE score. 
e-Figure 12. Probability of hospital mortality versus the proportion of time with SpO2 within 94% to 98% while 
controlling for APACHE score 
These plots are analogous to Figures 3A and 3B of the main text but control for APACHE instead of SOFA score while 
fitting the model on 24,855/8,564 ICU stays from eICU-CRD/MIMIC that have an APACHE score. 
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Subgroup analyses 
The first subgroup analysis is by ventilation type. The ventilation type could not be determined for all ICU stays. These 
results are based on 14,148/7,860 ICU stays with invasive ventilation and 3,641/697 ICU stays with supplemental 
oxygen or non-invasive ventilation from eICU-CRD/MIMIC, respectively. 
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e-Figure 13. Probability of hospital mortality versus median SpO2 grouped by ventilation type 
These plots are analogous to Figure 2 of the main text but group the ICU stays by their ventilation types. 
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e-Figure 14. Probability of hospital mortality versus the proportion of time with SpO2 within 94% to 98% grouped 
by ventilation type 
These plots are analogous to Figures 3A and 3B of the main text but group the ICU stays by their ventilation types. 
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The second subgroup analysis is by ICU type. The results for eICU-CRD are based on 6,963 stays in the cardiac ICU, 
2,613 stays in the medical ICU, 2,202 stays in the Surgical ICU, 12,400 stays in the medical-surgical ICU, and 2,545 
stays in the neuro ICU. The results for MIMIC are based on 3,073 stays in the cardiac surgery recovery unit, 1,932 
stays in the medical ICU, 1,349 stays in the surgical ICU, 1,199 stays in coronary care unit, and 1,010 stays in the 
trauma/surgical ICU. Henceforth, we do not control for hospital in eICU-CRD for numerical stability. 
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e-Figure 15. Probability of hospital mortality versus median SpO2 grouped by ICU type 
These plots are analogous to Figure 2 of the main text but group the ICU stays by their unit’s type. 
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e-Figure 16. Probability of hospital mortality versus the proportion of time with SpO2 within 94% to 98% grouped 
by ICU type 
These plots are analogous to Figures 3A and 3B of the main text but group the ICU stays by their unit’s type. 
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The third subgroup analysis is by ethnicity. The results are based on 21,123/6,038 Caucasian, 3,090/469 African-
American, 819/248 Hispanic, and 253/157 Asian patients from eICU-CRD/MIMIC, respectively. 
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e-Figure 17. Probability of hospital mortality versus median SpO2 grouped by ethnicity 
These plots are analogous to Figure 2 of the main text but group the ICU stays by their patient’s ethnicity. 
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e-Figure 18. Probability of hospital mortality versus the proportion of time with SpO2 within 94% to 98% grouped 
by ethnicity 
These plots are analogous to Figures 3A and 3B of the main text but group the ICU stays by their patient’s ethnicity. 
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The fourth subgroup analysis is based on the presence of diagnoses and comorbidities. The diagnoses considered are 
atrial fibrillation, cancer, congestive heart failure, chronic kidney disease, chronic liver disease, chronic obstructive 
pulmonary disease (COPD), diabetes mellitus, hypertension, ischemic heart disease, sepsis, and stroke. The diagnoses 
were determined by ICD-9 diagnosis codes. We present the results as in Figures 2, 3A, and 3B but with a different 
range on the vertical axis. 
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e-Figure 19. Results for ICU stays with an atrial fibrillation diagnosis  
4,550/3,838 patients in eICU-CRD/MIMIC had an atrial fibrillation diagnosis. 
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e-Figure 20. Results for ICU stays with a cancer diagnosis  
1,413/984 patients in eICU-CRD/MIMIC had a cancer diagnosis. 
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e-Figure 21. Results for ICU stays with a congestive heart failure diagnosis  
2,795/2,633 patients in eICU-CRD/MIMIC had a congestive heart failure diagnosis. 
 17 
 
 
  
eICU−CRD
Median oxygen saturation (SpO2)
Pr
ob
ab
ilit
y o
f h
os
pit
al 
mo
rta
lity
0%
20%
40%
60%
80%
100%
92% 94% 96% 98% 100%
A
MIMIC
Median oxygen saturation (SpO2)
Pr
ob
ab
ilit
y o
f h
os
pit
al 
mo
rta
lity
0%
20%
40%
60%
80%
100%
92% 94% 96% 98% 100%
B
Proportion of SpO2 measurements within 94% to 98%
Pr
ob
ab
ilit
y o
f h
os
pit
al 
mo
rta
lity
0%
20%
40%
60%
80%
100%
0% 20% 40% 60% 80% 100%
C
Proportion of SpO2 measurements within 94% to 98%
Pr
ob
ab
ilit
y o
f h
os
pit
al 
mo
rta
lity
0%
20%
40%
60%
80%
100%
0% 20% 40% 60% 80%
D
e-Figure 22. Results for ICU stays with a chronic kidney disease diagnosis  
2,155/881 patients in eICU-CRD/MIMIC had a chronic kidney disease diagnosis. 
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e-Figure 23. Results for ICU stays with a chronic liver disease diagnosis  
284/532 patients in eICU-CRD/MIMIC had a chronic liver disease diagnosis. 
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e-Figure 24. Results for ICU stays with a COPD diagnosis  
2,878/1,656 patients in eICU-CRD/MIMIC had a COPD diagnosis. 
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e-Figure 25. Results for ICU stays with a diabetes mellitus diagnosis  
493/2,389 patients in eICU-CRD/MIMIC had a diabetes mellitus diagnosis. 
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e-Figure 26. Results for ICU stays with a hypertension diagnosis  
3,637/4,806 patients in eICU-CRD/MIMIC had a hypertension diagnosis. 
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e-Figure 27. Results for ICU stays with an ischemic heart disease diagnosis  
2,075/3,701 patients in eICU-CRD/MIMIC had an ischemic heart disease diagnosis. 
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e-Figure 28. Results for ICU stays with a sepsis diagnosis  
2,750/1,327 patients in eICU-CRD/MIMIC had a sepsis diagnosis. 
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e-Figure 29. Results for ICU stays with a stroke diagnosis  
597/372 patients in eICU-CRD/MIMIC had a stroke diagnosis. 
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e-Figure 30. Histograms of proportion of SpO2 measurements within 94% to 98% and above 98% 
The histograms cover 26,723/8,564 ICU stays from eICU-CRD/MIMIC. 
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Causal inference 
So far, the analysis has focused on the effect of the exposure, SpO2, conditional on the control variables. Alternatively, 
one can consider the marginal effect of the exposure, that is the effect averaged over the control variables, also known 
as the average treatment effect. Causal inference methods provide computation of average treatment effects. We use G-
computation as it is well-suited to a continuous exposure:1 
To obtain the counterfactual mortality risk at unobserved exposures, we use the generalized additive models described 
in the main text. They provide mortality risk for any proportion of SpO2 within the 94–98% range for each patient in 
the data. We do this for the proportions 0%, 10%, 20%, …, 90%, 100%. For each proportion, we can average the 
counterfactual risk of all patients to obtain an average treatment effect. The results are in e-Figure 31. The confidence 
intervals follow from standard errors that were estimate from 100 bootstrap samples. While the effect sizes vary from 
the results in Figure 3 due to being the average treatment effect, the overall trend is the same. 
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e-Figure 31. Probability of hospital mortality versus the proportion of time with SpO2 within 94% to 98% based on 
G-computation. 
These plots are analogous to Figures 3A and 3B of the main text but show the average treatment effects based on G-
computation instead of the treatment effect conditional on the control variables. 
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Literature review 
We searched PubMed up to Feb 7, 2019, using the search terms ("hyperoxia"[MeSH Terms] OR "oxygen"[MeSH 
Terms]) AND "humans"[MeSH Terms] AND "adult"[MeSH Terms] AND "mortality"[MeSH Terms], and found 1 
systematic review of randomized trials,2 2 systematic reviews of observational studies involving cardiac arrest 
patients,3,4 4 systematic reviews of observational studies and randomized trials involving multiple types of critically ill 
patients,5-8 and 8 observational studies not included in the systematic reviews.9-16 
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